Skip to main content
Tech.euFundingExplorerBeta

Arthex Biotech

AntagomiR oligonucleotides to treat Myotonic Dystrophy patients.

Valencia, SpainFounded 2019arthexbiotech.com ↗
Healthtech
← All companies
Total raised
€78M
€78,150,000
Funding rounds
4
Investors
11
distinct backers
Active since
2020-07

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood45
base rate 48% for Series B
  • ▲ In typical raise window
  • ▼ Down/flat last round
  • ▼ Low backer re-investment
Exit likelihood19
base rate 12% (2+ rounds)
  • ▲ 3 rounds raised
  • ▲ €30M+ raised
  • ▲ 7y since founding

Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

4 rounds
DateStageAmountInvestors
—Other——View deal →
2025-09-22Series B€32MAdBio partners,Bpifrance,CDTI Innovación (Innvierte),Columbus Venture Partners,European Innovation Council (EIC),Hadean Ventures+2 moreView deal →
2023-05-03Series B€42MAdBio partners,Centre for the Development of Industrial Technology (CDTI),Columbus Venture Partners,European Innovation Council (EIC),Hadean Ventures,Invivo Capital Partners+1 moreView deal →
2020-07-23Seed€4.3MAdvent France Biotechnology,Invivo Capital PartnersView deal →

Investors

11
AdBio partnersAdvent France BiotechnologyBpifranceCDTI Innovación (Innvierte)Centre for the Development of Industrial Technology (CDTI)Columbus Venture PartnersEuropean Innovation Council (EIC)Hadean VenturesInvivo Capital PartnersInvivo PartnersSound Bioventures

Related news

Similar companies

same sector or country